rdf:type |
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0079419,
umls-concept:C0080347,
umls-concept:C0185117,
umls-concept:C0205263,
umls-concept:C0237477,
umls-concept:C0249197,
umls-concept:C0288472,
umls-concept:C0598894,
umls-concept:C1420626,
umls-concept:C1421709,
umls-concept:C2911684
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-29
|
pubmed:abstractText |
Upon DNA damage, p53 can induce either cell-cycle arrest or apoptosis. Here we show that monocytic leukemia zinc finger (MOZ) forms a complex with p53 to induce p21 expression and cell-cycle arrest. The levels of the p53-MOZ complex increased in response to DNA damage to levels that induce cell-cycle arrest. MOZ(-/-) mouse embryonic fibroblasts failed to arrest in G1 in response to DNA damage, and DNA damage-induced expression of p21 was impaired in MOZ(-/-) cells. These results suggest that MOZ is involved in regulating cell-cycle arrest in the G1 phase. Screening of tumor-associated p53 mutants demonstrated that the G279E mutation in p53 disrupts interactions between p53 and MOZ, but does not affect the DNA binding activity of p53. The leukemia-associated MOZ-CBP fusion protein inhibits p53-mediated transcription. These results suggest that inhibition of p53/MOZ-mediated transcription is involved in tumor pathogenesis and leukemogenesis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cdkn1a protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Histone Acetyltransferases,
http://linkedlifedata.com/resource/pubmed/chemical/KAT6A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/MOZ protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/TP53 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0021-9258
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
237-44
|
pubmed:dateRevised |
2011-10-3
|
pubmed:meshHeading |
pubmed-meshheading:19001415-Animals,
pubmed-meshheading:19001415-Cell Line,
pubmed-meshheading:19001415-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:19001415-Embryo, Mammalian,
pubmed-meshheading:19001415-Fibroblasts,
pubmed-meshheading:19001415-G1 Phase,
pubmed-meshheading:19001415-Gene Expression Regulation,
pubmed-meshheading:19001415-Histone Acetyltransferases,
pubmed-meshheading:19001415-Humans,
pubmed-meshheading:19001415-Mice,
pubmed-meshheading:19001415-Mice, Knockout,
pubmed-meshheading:19001415-Protein Binding,
pubmed-meshheading:19001415-Recombinant Fusion Proteins,
pubmed-meshheading:19001415-Tumor Suppressor Protein p53
|
pubmed:year |
2009
|
pubmed:articleTitle |
Monocytic leukemia zinc finger (MOZ) interacts with p53 to induce p21 expression and cell-cycle arrest.
|
pubmed:affiliation |
Molecular Oncology Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|